Amylyx Pharmaceuticals, Inc.AMLXNASDAQ
Loading
Operating cash flow minus capital expenditures
Percentile
P33
Within normal range
vs 2Y Ago
-11.6x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-123.48M | +26.4% |
| 2024 | $-167.80M | -1671.5% |
| 2023 | $10.68M | +105.9% |
| 2022 | $-182.40M | -142.7% |
| 2021 | $-75.15M | -104.0% |
| 2020 | $-36.85M | -244.8% |
| 2019 | $-10.69M | - |